News & Updates
The latest news and advances from the world's most exciting life science cluster.
Phase Genomics, a Seattle-based life science company, that maps and analyzes genomes, is focusing its attention inward and renewing its R&D efforts during the pandemic.
Seattle Children’s Hospital and Prevencio: The Hunt to Understand COVID-19’s Connection to Kawasaki Disease
Seattle Children’s Hospital is working with blood-testing startup Prevencio to develop a blood test to detect certain proteins and blood components leading to a firm
Seattle researchers building ‘biobank’ of patients’ blood to unlock the mysteries of the new coronavirus
The Institute for Systems Biology (ISB) and Swedish Health are building a “biobank” to study COVID-19’s impact on the human body. According to Dr. Jim
Seattle headquartered, Nautilus Biotechnology announced a $76 million series B round to fund its work analyzing and quantifying the human proteome. Nautilus Biotechnology is looking
Kineta Inc. CEO, Shawn Iadonato recently spoke to PSBJ about laying the groundwork for an IPO. Iadonato told PSBJ’s Megan Campbell, “We’re really watching the capital markets closely.
Seattle-based Seattle Genetics and Astellas’ new bladder cancer treatment, Pandcev exceeded sales expectations in Q1. In a note to clients, J.P. Morgan analyst, Cory Kasimov